BioIntelliSense Announces Completion of Houston Methodist Inpatient Expansion of the BioButton

The BioIntelliSense FDA-cleared BioButton® multiparameter wearable is now monitoring tens of thousands of patients across more than 2,600 non-ICU beds across Houston Methodist as part of the leading healthcare system’s… The post BioIntelliSense Announces Completion of Houston Methodist Inpatient Expansion of the BioButton appeared first on BioIntelliSense .